Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electromyographic Record of Classical Conditioning of Eye Withdrawal in the Crab.

The Biological bulletin·2018
Same author

Obesity, waist-hip ratio and hunter-gatherers.

BJOG : an international journal of obstetrics and gynaecology·2007
Same author

Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice.

The British journal of ophthalmology·2006
Same author

To: McAuley KA, Hopkins CM, Smith KJ, McLay RT, Williams SM, Taylor RW, Mann JI (2005) Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 48:8-16.

Diabetologia·2005
Same author

The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation.

The British journal of ophthalmology·2004
Same author

Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen.

Cytokine·2002
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Interrelations of platelet aggregation and secretion.

I F Charo, R D Feinman, T C Detwiler

    The Journal of Clinical Investigation
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Human platelet activation involves two distinct pathways: aggregation-mediated, which requires aggregation and is indomethacin-sensitive, and direct activation, which is independent of aggregation and indomethacin-resistant.

    More Related Videos

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
    11:42

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

    Published on: July 10, 2017

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
    05:49

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

    Published on: November 29, 2024

    Related Experiment Videos

    Last Updated: Jun 8, 2026

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
    10:10

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

    Published on: October 27, 2009

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
    11:42

    Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

    Published on: July 10, 2017

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
    05:49

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

    Published on: November 29, 2024

    Area of Science:

    • Hematology
    • Cellular Biology
    • Biochemistry

    Background:

    • Understanding platelet activation mechanisms is crucial for hemostasis and thrombosis research.
    • Previous studies have explored platelet aggregation and secretion separately, limiting a comprehensive view of stimulus-response coupling.

    Purpose of the Study:

    • To investigate the distinct mechanisms of human platelet activation.
    • To differentiate between aggregation-mediated and directly induced platelet activation pathways.

    Main Methods:

    • Simultaneous monitoring of platelet aggregation and secretion in platelet-rich plasma using a novel instrument.
    • Stimulation of platelets with various agonists including ADP, epinephrine, gamma-thrombin, A23187, and collagen at different concentrations.
    • Assessment of indomethacin's effect on platelet activation.

    Main Results:

    • Two distinct platelet activation mechanisms were identified: aggregation-mediated and direct activation.
    • Aggregation-mediated activation, observed with high ADP or low thrombin/A23187, is dependent on aggregation and inhibited by indomethacin.
    • Direct activation, seen with low ADP, epinephrine, high thrombin/A23187, and collagen, occurs independently of aggregation and is indomethacin-resistant.
    • Secretion and second-wave aggregation appear to be parallel events, not causally linked.

    Conclusions:

    • Human platelet stimulus-response coupling involves two independent pathways: aggregation-mediated and direct activation.
    • Aggregation-mediated activation is sensitive to indomethacin, while direct activation is not.
    • These findings provide a refined model for understanding platelet activation dynamics.